Gazyva

List of products in the National Drug Code with proprietary name gazyva. Obinutuzumab is used to treat certain types of blood cancer (such as chronic lymphocytic leukemia, follicular lymphoma). Obinutuzumab belongs to a class of drugs known as monoclonal antibodies. It works by stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
50242-070Gazyva ObinutuzumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.Human Prescription Drug